CVS Health CEO Karen Lynch has stepped down amid struggles for the national drugstore chain, with shares down 19%. David Joyner will take over as CEO to navigate the challenges of rising medical costs and increased competition. Joyner, with 37 years of experience in health care and pharmacy benefit management, aims to lead CVS Health through the changing landscape. The company’s preliminary forecast for third-quarter earnings is lower than expected, prompting the leadership change. Chairman Roger Farah will now serve as executive chairman to support Joyner in addressing industry challenges and driving operational improvements.
